| Dr H Stephen Beyer, MD | |
|
7900 W Jefferson Blvd Ste 201, Fort Wayne, IN 46804-4128 | |
| (260) 432-2297 | |
| Not Available |
| Full Name | Dr H Stephen Beyer |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 46 Years |
| Location | 7900 W Jefferson Blvd Ste 201, Fort Wayne, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518915800 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 01048623A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lutheran Hospital Of Indiana | Fort wayne, IN | Hospital |
| Kosciusko Community Hospital | Warsaw, IN | Hospital |
| Bluffton Regional Medical Center | Bluffton, IN | Hospital |
| Dupont Hospital Llc | Fort wayne, IN | Hospital |
| Adams Memorial Hospital | Decatur, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lutheran Medical Group Llc | 4981751617 | 261 |
News Archive
The latest issue of Pathogens and Global Health highlights the current debate surrounding the under-investigated, and politically sensitive, issue of counterfeit medicine. Issue 106.2 includes an interview with Dr Paul Newton, Head of the Laos arm of the Wellcome Trust's Major Overseas Programmes, and a number of articles highlighting the technological innovations and field initiatives that are challenging this threat to global health.
The University of Illinois at Chicago received $1.7 million in research funding from the U.S. Department of Housing and Urban Development to study lead and other household health hazards. The funds will support two different projects in Illinois communities.
When reactive oxygen species (ROS) hit the body, vitamin E helps to prevent damage to tissues and cells by acting as an antioxidant. The health benefits of vitamin E are numerous, and in fact, studies have found that people with higher levels of vitamin E in their system have a lower risk of heart disease and certain forms of cancer. A team led by Thomas Rosenau from the University of Natural Resources and Life Sciences in Vienna (Austria) now describe their synthesis of a series of modified vitamin E derivatives that show promise as dioxin receptor antagonists in the European Journal of Organic Chemistry.
To create treatments for a disease without any, scientists need to study and understand the driving forces behind the faulty biology. Today, researchers at the University of North Carolina School of Medicine announced the first-ever evidence-based description of the neuronal protein clumps thought to be important in Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease, a fatal neurodegenerative condition.
Kentucky health officials are considering restrictions on the number of cancer-fighting drugs Medicaid patients may receive without prior approval, a move designed to contain costs in the health care program for the poor and disabled. The possibility of creating a non-preferred list of oral oncology drugs — pills that replace intravenous chemotherapy drugs — that Medicaid won't pay for without prior approval has raised questions from patient advocates and those who treat cancer patients.
› Verified 9 days ago
| Entity Name | Lutheran Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164662805 PECOS PAC ID: 4981751617 Enrollment ID: O20090414000705 |
News Archive
The latest issue of Pathogens and Global Health highlights the current debate surrounding the under-investigated, and politically sensitive, issue of counterfeit medicine. Issue 106.2 includes an interview with Dr Paul Newton, Head of the Laos arm of the Wellcome Trust's Major Overseas Programmes, and a number of articles highlighting the technological innovations and field initiatives that are challenging this threat to global health.
The University of Illinois at Chicago received $1.7 million in research funding from the U.S. Department of Housing and Urban Development to study lead and other household health hazards. The funds will support two different projects in Illinois communities.
When reactive oxygen species (ROS) hit the body, vitamin E helps to prevent damage to tissues and cells by acting as an antioxidant. The health benefits of vitamin E are numerous, and in fact, studies have found that people with higher levels of vitamin E in their system have a lower risk of heart disease and certain forms of cancer. A team led by Thomas Rosenau from the University of Natural Resources and Life Sciences in Vienna (Austria) now describe their synthesis of a series of modified vitamin E derivatives that show promise as dioxin receptor antagonists in the European Journal of Organic Chemistry.
To create treatments for a disease without any, scientists need to study and understand the driving forces behind the faulty biology. Today, researchers at the University of North Carolina School of Medicine announced the first-ever evidence-based description of the neuronal protein clumps thought to be important in Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease, a fatal neurodegenerative condition.
Kentucky health officials are considering restrictions on the number of cancer-fighting drugs Medicaid patients may receive without prior approval, a move designed to contain costs in the health care program for the poor and disabled. The possibility of creating a non-preferred list of oral oncology drugs — pills that replace intravenous chemotherapy drugs — that Medicaid won't pay for without prior approval has raised questions from patient advocates and those who treat cancer patients.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr H Stephen Beyer, MD 7900 W Jefferson Blvd Ste 201, Fort Wayne, IN 46804-4128 Ph: (260) 432-2297 | Dr H Stephen Beyer, MD 7900 W Jefferson Blvd Ste 201, Fort Wayne, IN 46804-4128 Ph: (260) 432-2297 |
News Archive
The latest issue of Pathogens and Global Health highlights the current debate surrounding the under-investigated, and politically sensitive, issue of counterfeit medicine. Issue 106.2 includes an interview with Dr Paul Newton, Head of the Laos arm of the Wellcome Trust's Major Overseas Programmes, and a number of articles highlighting the technological innovations and field initiatives that are challenging this threat to global health.
The University of Illinois at Chicago received $1.7 million in research funding from the U.S. Department of Housing and Urban Development to study lead and other household health hazards. The funds will support two different projects in Illinois communities.
When reactive oxygen species (ROS) hit the body, vitamin E helps to prevent damage to tissues and cells by acting as an antioxidant. The health benefits of vitamin E are numerous, and in fact, studies have found that people with higher levels of vitamin E in their system have a lower risk of heart disease and certain forms of cancer. A team led by Thomas Rosenau from the University of Natural Resources and Life Sciences in Vienna (Austria) now describe their synthesis of a series of modified vitamin E derivatives that show promise as dioxin receptor antagonists in the European Journal of Organic Chemistry.
To create treatments for a disease without any, scientists need to study and understand the driving forces behind the faulty biology. Today, researchers at the University of North Carolina School of Medicine announced the first-ever evidence-based description of the neuronal protein clumps thought to be important in Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease, a fatal neurodegenerative condition.
Kentucky health officials are considering restrictions on the number of cancer-fighting drugs Medicaid patients may receive without prior approval, a move designed to contain costs in the health care program for the poor and disabled. The possibility of creating a non-preferred list of oral oncology drugs — pills that replace intravenous chemotherapy drugs — that Medicaid won't pay for without prior approval has raised questions from patient advocates and those who treat cancer patients.
› Verified 9 days ago
Dr. Dustin M Thomas, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 11108 Parkview Plaza Dr, Fort Wayne, IN 46845 Phone: 260-266-5700 Fax: 260-266-5910 | |
Ahmad Alhariri, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 11109 Parkview Plaza Dr, Fort Wayne, IN 46845 Phone: 260-266-2020 | |
Dr. Anuradha G Bommakanti, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 7950 W Jefferson Blvd, Fort Wayne, IN 46804 Phone: 260-435-7001 | |
Eileen Jill Ramos Muzzillo, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 4402 E State Blvd, Fort Wayne, IN 46815 Phone: 260-425-5600 Fax: 260-425-5605 | |
John T Ducker, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 7836 W Jefferson Blvd, Suite 101, Fort Wayne, IN 46804 Phone: 260-494-3484 Fax: 260-969-0188 | |
Mr. Kenneth A Smith, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 1234 East Dupont Road, Suite 5, Fort Wayne, IN 46825 Phone: 260-489-1666 Fax: 260-489-3255 | |
Dr. Carl Marc Williams, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 11104 Parkview Circle Dr, Fort Wayne, IN 46845 Phone: 260-373-9700 Fax: 260-373-9740 |